Literature DB >> 29625874

Peripheral neuropathy is associated with more frequent falls in Parkinson's disease.

Mélanie L Beaulieu1, Martijn L T M Müller2, Nicolaas I Bohnen3.   

Abstract

INTRODUCTION: Peripheral neuropathy is a common condition in the elderly that can affect balance and gait. Postural imbalance and gait difficulties in Parkinson's disease (PD), therefore, may stem not only from the primary neurodegenerative process but also from age-related medical comorbidities. Elucidation of the effects of peripheral neuropathy on these difficulties in PD is important to provide more targeted and effective therapy. The purpose of this study was to investigate the association between lower-limb peripheral neuropathy and falls and gait performance in PD while accounting for disease-specific factors.
METHODS: From a total of 140 individuals with PD, 14 male participants met the criteria for peripheral neuropathy and were matched 1:1 for Hoehn & Yahr stage and duration of disease with 14 male participants without peripheral neuropathy. All participants underwent fall (retrospectively) and gait assessment, a clinical evaluation, and [11C]dihydrotetrabenazine and [11C]methylpiperidin-4-yl propionate PET imaging to assess dopaminergic and cholinergic denervation, respectively.
RESULTS: The presence of peripheral neuropathy was significantly associated with more falls (50% vs. 14%, p = 0.043), as well as a shorter stride length (p = 0.011) and greater stride length variability (p = 0.004), which resulted in slower gait speed (p = 0.016) during level walking. There was no significant difference in nigrostriatal dopaminergic denervation, cortical and thalamic cholinergic denervation, and MDS-UPDRS motor examination scores between groups.
CONCLUSION: Lower-limb peripheral neuropathy is significantly associated with more falls and gait difficulties in PD. Thus, treating such neuropathy may reduce falls and/or improve gait performance in PD.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fall; Gait; Neuropathy; Parkinson's disease

Mesh:

Year:  2018        PMID: 29625874      PMCID: PMC6163065          DOI: 10.1016/j.parkreldis.2018.04.006

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  27 in total

1.  The effects of a home exercise program on impairment and health-related quality of life in persons with chronic peripheral neuropathies.

Authors:  J L Ruhland; R K Shields
Journal:  Phys Ther       Date:  1997-10

2.  Moderate peripheral neuropathy impairs weight transfer and unipedal balance in the elderly.

Authors:  J K Richardson; J A Ashton-Miller; S G Lee; K Jacobs
Journal:  Arch Phys Med Rehabil       Date:  1996-11       Impact factor: 3.966

3.  Unipedal stance testing in the assessment of peripheral neuropathy.

Authors:  E A Hurvitz; J K Richardson; R A Werner
Journal:  Arch Phys Med Rehabil       Date:  2001-02       Impact factor: 3.966

4.  Imbalanced: The Confusing Circular Nature of Falls Research…and a Possible Antidote.

Authors:  James K Richardson
Journal:  Am J Phys Med Rehabil       Date:  2017-01       Impact factor: 2.159

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study.

Authors:  B H Wood; J A Bilclough; A Bowron; R W Walker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

7.  Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.

Authors:  S Nagatsuka Si; K Fukushi; H Shinotoh; H Namba; M Iyo; N Tanaka; A Aotsuka; T Ota; S Tanada; T Irie
Journal:  J Cereb Blood Flow Metab       Date:  2001-11       Impact factor: 6.200

Review 8.  Normal and pathological gait: what we learn from Parkinson's disease.

Authors:  David Grabli; Carine Karachi; Marie-Laure Welter; Brian Lau; Etienne C Hirsch; Marie Vidailhet; Chantal François
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-06-29       Impact factor: 10.154

9.  In vivo imaging of the brain vesicular monoamine transporter.

Authors:  T M Vander Borght; M R Kilbourn; R A Koeppe; J N DaSilva; J E Carey; D E Kuhl; K A Frey
Journal:  J Nucl Med       Date:  1995-12       Impact factor: 10.057

10.  Prevalence and burden of gait disorders in elderly men and women aged 60-97 years: a population-based study.

Authors:  Philipp Mahlknecht; Stefan Kiechl; Bastiaan R Bloem; Johann Willeit; Christoph Scherfler; Arno Gasperi; Gregorio Rungger; Werner Poewe; Klaus Seppi
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more
  7 in total

1.  Decreased vestibular efficacy contributes to abnormal balance in Parkinson's disease.

Authors:  Nicolaas I Bohnen; Stiven Roytman; Alexis Griggs; Simon M David; Mélanie L Beaulieu; Martijn L T M Müller
Journal:  J Neurol Sci       Date:  2022-07-28       Impact factor: 4.553

Review 2.  Movement disorders and neuropathies: overlaps and mimics in clinical practice.

Authors:  Francesco Gentile; Alessandro Bertini; Alberto Priori; Tommaso Bocci
Journal:  J Neurol       Date:  2022-06-03       Impact factor: 6.682

Review 3.  The Impact of Footwear on Occupational Task Performance and Musculoskeletal Injury Risk: A Scoping Review to Inform Tactical Footwear.

Authors:  Robin Orr; Danny Maupin; Robert Palmer; Elisa F D Canetti; Vini Simas; Ben Schram
Journal:  Int J Environ Res Public Health       Date:  2022-08-27       Impact factor: 4.614

Review 4.  Potential use of corneal confocal microscopy in the diagnosis of Parkinson's disease associated neuropathy.

Authors:  Ning-Ning Che; Hong-Qi Yang
Journal:  Transl Neurodegener       Date:  2020-07-02       Impact factor: 8.014

5.  Wearable Health Technology to Quantify the Functional Impact of Peripheral Neuropathy on Mobility in Parkinson's Disease: A Systematic Review.

Authors:  Marta Francisca Corrà; Elke Warmerdam; Nuno Vila-Chã; Walter Maetzler; Luís Maia
Journal:  Sensors (Basel)       Date:  2020-11-19       Impact factor: 3.576

6.  Tolcapone improves outcomes in patients with Parkinson disease treated by levodopa/carbidopa intestinal gel: A pilot study.

Authors:  Peter Valkovič; Michal Minár; Peter Matejička; Karin Gmitterová; Veronika Boleková; Zuzana Košutzká
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

7.  Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease.

Authors:  Chen Qiao; Qian Zhang; Qingling Jiang; Ting Zhang; Miaomiao Chen; Yi Fan; Jianhua Ding; Ming Lu; Gang Hu
Journal:  J Neuroinflammation       Date:  2018-07-02       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.